Vitrolife AB (publ) (OTCMKTS:VTRLY) Shares Down 0.8% – Should You Sell?

Vitrolife AB (publ) (OTCMKTS:VTRLY)’s stock price fell 0.8% on Thursday . The company traded as low as $9.50 and last traded at $9.50. 225 shares traded hands during mid-day trading, a decline of 86% from the average daily volume of 1,643 shares. The stock had previously closed at $9.58.

Vitrolife AB (publ) Trading Down 0.8%

The company’s fifty day simple moving average is $10.84 and its 200-day simple moving average is $11.79.

Vitrolife AB (publ) Company Profile

Vitrolife AB (publ) is a Sweden‐based life science company specializing in products and systems for in vitro fertilization (IVF) and assisted reproductive technologies. Founded in 1994 and headquartered in Gothenburg, the company develops, manufactures and markets a comprehensive portfolio of consumables, culture media and instruments that support the entire IVF process, from gamete handling to embryo culture and cryopreservation.

The company’s product range includes embryo culture media, blastocyst media, vitrification solutions and pipetting tools designed to optimize laboratory workflows and improve outcomes for fertility clinics and patients.